Breast Carcinoma Survivors
Item
breast cancer survivors
boolean
C0678222 (UMLS CUI [1,1])
C0206194 (UMLS CUI [1,2])
Early-Stage Breast Carcinoma TNM Breast tumor staging | DCIS
Item
hx of early-stage breast cancer (dcis and stages i, ii and iii)as recorded in the medical record at mskcc or by self-report or by outside correspondence, including a study checklist signed by a physician for patients outside of mskcc.
boolean
C2986665 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0007124 (UMLS CUI [2])
Treatment completed Breast Carcinoma | Hormone Therapy | Tamoxifen | Recurrence Absent | Neoplasm Metastasis Absent
Item
≥ 3 months post completion of breast cancer treatment (may be on hormone therapy, such as tamoxifen) with no history of recurrence or metastasis as confirmed by the medical record at mskcc, self- report or by outside correspondence
boolean
C0580352 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2])
C0039286 (UMLS CUI [3])
C0034897 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0027627 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Age
Item
age 18 or older
boolean
C0001779 (UMLS CUI [1])
Able to read English Language | Able to speak English Language
Item
able to read and speak english
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0564215 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Fear Index Score | Other Coding
Item
an overall fear index score of ≥ 3.0 on the cars
boolean
C0015726 (UMLS CUI [1,1])
C0918012 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C3846158 (UMLS CUI [2])
Mood Stabilizer | Anti-Anxiety Agents | Antidepressive Agents | Pharmaceutical Preparations Hallucinations | Sleeping pill | Pharmaceutical Preparations Dosage Stable | Change Clinical Significance Lacking
Item
if taking medication for mood, anxiety, depression, thoughts, sensory experiences such as hallucinations, or sleep, stable and consistent enough in dosage and use of that medication so as to not result in a clinically significant change as determined by the study pi/co-pi or confirmed by reports in the medical record at mskcc or by self-report or by outside correspondence, including a study checklist signed by a physician for patients outside of mskcc
boolean
C2917435 (UMLS CUI [1])
C0040616 (UMLS CUI [2])
C0003289 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0018524 (UMLS CUI [4,2])
C0599396 (UMLS CUI [5])
C0013227 (UMLS CUI [6,1])
C0178602 (UMLS CUI [6,2])
C0205360 (UMLS CUI [6,3])
C0392747 (UMLS CUI [7,1])
C2826293 (UMLS CUI [7,2])
C0332268 (UMLS CUI [7,3])
Psychotherapy Stable | Exception Cognitive Therapy
Item
if in non-cbt psychotherapy, stable for at least 8 weeks
boolean
C0033968 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0009244 (UMLS CUI [2,2])
Access Computer | Intervention Completion | Follow-up Assessment
Item
access to a computer or willingness to come to mskcc to complete intervention sessions 2-8 and the 3-month follow-up assessment, if no personal computer.
boolean
C0444454 (UMLS CUI [1,1])
C0009622 (UMLS CUI [1,2])
C0184661 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C3274571 (UMLS CUI [3,1])
C1516048 (UMLS CUI [3,2])
Clinical Trial Part Number
Item
for part 2 only, did not participate in part 1
boolean
C0008976 (UMLS CUI [1,1])
C0449719 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
Second Primary Cancer | Therapeutic procedure Second Primary Cancer | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
evidence of or treatment for a second primary of cancer except basal or squamous cell carcinoma of the skin as confirmed by the medical record at mskcc, by self-report, or by outside correspondence
boolean
C0751623 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0751623 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
Mental disorder Excludes Informed Consent | Mental disorder Excludes Participation Intervention | Impaired cognition Excludes Informed Consent | Impaired cognition Excludes Participation Intervention | Psychiatric symptoms Requirement Individual psychiatric therapy
Item
significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the interventions (i.e., acute psychiatric symptoms which require individual treatment).
boolean
C0004936 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0004936 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0679823 (UMLS CUI [2,3])
C0184661 (UMLS CUI [2,4])
C0338656 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0021430 (UMLS CUI [3,3])
C0338656 (UMLS CUI [4,1])
C0332196 (UMLS CUI [4,2])
C0679823 (UMLS CUI [4,3])
C0184661 (UMLS CUI [4,4])
C0233401 (UMLS CUI [5,1])
C1514873 (UMLS CUI [5,2])
C2048936 (UMLS CUI [5,3])
Participation Cognitive Therapy
Item
current participation in cognitive-behavioral therapy (cbt), as confirmed by either self-report* or the medical record which also targets cognitive biases.
boolean
C0679823 (UMLS CUI [1,1])
C0009244 (UMLS CUI [1,2])